Biological or targeted synthetic DMARDs increase COVID-19 severity
Tài liệu tham khảo
Sparks J, et al. ASSOCIATIONS OF BASELINE USE OF BIOLOGIC OR TARGETED SYNTHETIC DMARDS WITH COVID-19 SEVERITY IN RHEUMATOID ARTHRITIS: RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE Annals of the Rheumatic Diseases 80 (Suppl. 1): 19 May 2021. Available from: URL: http://dx.doi.org/10.1136/annrheumdis-2021-eular.1632